|
In Memoriam – Dr. Mary Agnes Young,
February 4, 1948 – February 25, 2024
| |
|
The DC CFAR is sharing the sad news of the recent passing of Dr. Mary Young. An Infectious Diseases Physician at Georgetown University and the Principal Investigator of the DC Women's Interagency HIV Cohort (WIHS), Dr. Young was one of the founding investigator members of the DC CFAR and served as the Director of the DC CFAR Clinical & Population Sciences Core from 2011-2015. Dr. Young was a treasured colleague, clinician, collaborator, scientist, mentor and friend. Below please find a summary of her career and contributions sent by Dr. Princy Kumar and Dr. Seble Kassaye on behalf of the Division of Infectious Diseases and Tropical Medicine at the Georgetown University School of Medicine.
–
On the passing of Dr. Mary Agnes Young, much beloved member of the Georgetown University Division of Infectious Diseases and Tropical Medicine. After completing her undergraduate studies in English at the College of Notre Dame in Baltimore, and working briefly providing social services, Dr. Young completed her pre-medical coursework at Boston University. Dr. Young then graduated from the West Virginia University School of Medicine in 1984, and completed her residency and fellowship training in Internal Medicine (1987) and Infectious Diseases (1989) at Georgetown University Hospital. Dr. Young joined the faculty at Georgetown University in 1989 where she remained until her retirement in 2016.
Dr. Young’s early career was strongly influenced by the HIV pandemic and high number of persons with AIDS that were seeking care in DC hospitals in the period prior to the availability of antiretroviral therapy. Identifying the lack of specific research that focused on women, she led a city-wide multi-institutional effort to become a study site for the Women’s Interagency HIV Study (WIHS) in DC. Supported by colleagues from Howard University, Whitman Walker Clinic, Montgomery County in Maryland, and the INova Jupiter clinic in northern Virginia, Dr. Young successfully competed to bring to fruition a research portfolio focused on HIV and Women. She joined what would become a national network of friends and colleagues who shared her passion and conviction to improve the lives of women with HIV. With her tremendous collaborative spirit, Dr. Young contributed to research on the effects of HIV on women, all women. Her warmth and kindness pervaded the research environment that she developed, a caring place where women could come and be themselves, share their unfiltered stories without fear of judgement, and provide biologic samples. Her goal was not only to help us uncover the biologic effects of HIV, but also to highlight the role of social, behavioral, and structural constructs on important health and quality of life outcomes for women affected by HIV. She was able to see the rewards of the collective research efforts that led to scientific breakthroughs and life-saving therapies, as she steered her vibrant clinical practice in her role as Director of the HIV Women’s Program at Georgetown.
In addition to her pivotal role in the national WIHS study, Dr. Young supported research projects in the AIDS Clinical Trials Group in the study of the HPV vaccine among women with HIV, and as the Director for the Clinical Core of the DC Center For AIDS Research. Trusted by the local community, she served on the Board of Directors for the Women’s Collective, an advocacy group for DC women with HIV. Dr. Young was upheld as a woman of high integrity, and shared her wisdom and guidance as the Chair of the Georgetown Institutional Review Board, and as a volunteer on data safety and monitoring boards for NIH studies. She also served as a Medical Consultant to the Peace Corps and State Department in DC.
Dr. Young was a pillar of strength, and maintained amazing clarity and laser focus on what matters the most. Dr. Young was much loved by her patients, participants, the community of advocates who she worked with tirelessly in the early days of the pandemic, students, colleagues, fellow faculty members, and the many early-stage investigators whose careers she selflessly helped boost. We will remember and honor her for her kind and gentle ways, her love for family and friends, her commitment to remaining centered through meditation and mindfulness, her celebrations of her faiths, her humility and understanding of human frailties, unconditional support, and for being the consummate practitioner of rendering care with loving kindness.
| |
DC CFAR Developmental Core "My Path to Independence in HIV Research" Featuring Dr. Anthony Fauci, Thurs, March 21, from 4:00-5:00PM ET |  | |
Please join us for the DC CFAR Developmental Core Lecture Series: My Path to Independence in HIV Research. Each hour-long session in this series will showcase prominent researchers from across the country and autobiographical accounts of their careers in HIV research, specifically their pathways to career and research independence.
Our next lecture will feature Dr. Anthony Fauci, Distinguished University Professor in the Division of Infectious Diseases at Georgetown University School of Medicine and former Director of the National Institute of Allergy and Infectious Diseases at the National Institutes of Health (NIH). Dr. Fauci will discuss his perspectives on pursuing a research career in HIV-related science. We plan to follow his 30-minute presentation with a 30-minute Q&A session. We kindly ask that participants submit questions for Dr. Fauci in advance in the registration form linked below. Questions can be submitted in the chat box during the session as well.
Register for the seminar here.
| |
DC CFAR Women and HIV SIG and SGM SIG Virtual Seminar in recognition of National Women and Girls HIV/AIDS Awareness Day, Fri, March 8, 11-12PM ET |  | |
Please join the Women and HIV Scientific Interest Group (SIG) and Sexual and Gender Minorities (SGM) SIG for a virtual on Friday, March 8, from 11:00-12:00 pm ET. In recognition of National Women and Girls HIV/AIDS Awareness Day on March 10, the seminar will focus on HIV prevention for transgender women.
The event will feature presentations from DC CFAR member, Dr. Ana María del Río-González (left) and Women and HIV SIG Academic Co-Lead, Dr. Mimi Ghosh (right). Dr. del Río-González will present on "An Intersectionality-informed Understanding of HIV prevention among Latina Immigrant Transgender Women in the DC Metropolitan Area" and Dr. Ghosh will present on "Biological mechanisms of HIV risk in transgender women". The presentations will be followed by a panel discussion with CPC member, Tessa Jelani. Please register for the event at the link below."
Zoom Details:
https://us02web.zoom.us/j/85719634923?pwd=TXNGUnV2QTMxdCtPcFZYNGRWbjVVZz09
Meeting ID: 857 1963 4923
Passcode: 583417
Register Now!
| | |
DC CFAR Presenters and Award Recipients at CROI 2024 | |
The DC CFAR is proud to announce the investigators from DC CFAR institutions who presented their research and recieved awards at this year's Conference on Retroviruses & Opportunistic Infections (CROI) happening from March 3-6 in Denver, Colorado.
This includes investigators from Howard University (HU), George Washington University (GW), Georgetown University (GU), and Whitman Walker (WW). Please see the following presenters and awardees below:
- Mikaley Bolden (GU)
- Recipient of "Young Investigator" Award
- David Fessler (with Jonathon Rendina) (WW)
- Matilde Jacobson (GW)
- Recipient of "New Investigator Scholarship" Award
- Ezer Kang (HU)
- Lili (Xinyi) Li (GW)
- Recipient of "New Investigator Scholarship" Award
- Elyse McMahon (GW)
- Recipient of "Young Investigator" Award
- Teresa Murphy (GW)
- Sydney Nelson (GW)
- Lauren O’Connor (GW)
- Recipient of "Young Investigator" Award
- Michelle Premazzi Papa (GW)
- Recipient of "New Investigator Scholarship" Award
- Rachel Scott (GU)
- Peyton Thomas (GU)
Please join us in congratulating our DC CFAR investigators and awardees!
| |
DC CFAR Investigator, Dr. Irene Kuo (GW) and HPTN 094 Study Site Published in Trials | |
Dr. Irene Kuo (GW) and the multi-site team behind the HIV Prevention Trials Network (HPTN) 094 study recently published a paper in Trials titled “Delivering integrated strategies from a mobile unit to address the intertwining epidemics of HIV and addiction in people
who inject drugs: the HPTN 094 randomized controlled trial protocol (the INTEGRA Study).”
The article describes the methods for this study which is intended to test the efficacy of a “whole-person” care model that provides integrated HIV prevention, testing and treatment with treatment for opioid use disorder for people who inject drugs in a mobile health delivery unit.
To read more about the study and its methods, use the link here.
| | |
Do you have an event you would like to see included in the next edition of the Community Spotlight? We invite any news or updates from the DC CFAR community and encourage you to send information that may be of interest to CFARinDC@gmail.com. | |
|
Save the Date – National 2024 Ryan White Conference on HIV & Treatment (AIDSWatch)
March 17-19, 2024
Washington, DC
Inter-CFAR MACC School of Nursing (SON) Conference
May 2-3, 2024
Baltimore, MD
ACTHIV 2024: Registration Open
May 2-4, 2024
Atlanta, GA | Hybrid
SYNC 2024: Registration Now Open & Call for Abstracts
May 29-31, 2024
Washington, DC
19th International Conference on HIV Treatment & Prevention Adherence – Continuum 2024
June 9-11, 2024
Puerto Rico
IAS 2024
July 22-26
Munich, Germany
National LGBTQ+ Health Conference
August 15-17, 2024
Atlanta, GA
2024 National Ryan White Conference on HIV Care & Treatment
August 20-23, 2024
US Conference on HIV/AIDS (USCHA) 2024: Registration Open
September 12-15, 2024
New Orleans, LA
HIVR4P 2024, the 5th HIV Research for Prevention Conference (Registration Now Open and Application for Scholarships Available!)
October 6-10, 2024
Lima, Peru | Hybrid
For more DC CFAR events please see the calendar here.
| |
FUNDING, TRAINING, & MENTORING OPPORTUNITIES & SEMINARS | |
|
NEW – "Coffee, Cocktails, & Conversation: HIV & Black Women – We Talking About It" Facebook Live, March 10, 2024. Hosted by Community Education Group
"Join us for "Coffee, Cocktails, and Conversation" on March 10 at 5 pm EST to celebrate National Women and Girls HIV/AIDS Awareness Day! Prepare for an enriching Facebook and Instagram livestream featuring a dynamic panel of amazing Black women! Don't miss out on this empowering discussion! #WeAreAppalachia" Register here.
Modelers and Storytellers: Transdisciplinary Training to Advance Community Health Intervention Research, Priority Deadline due March 11th
The Modelers and Storytellers Transdisciplinary Training is a two-week virtual summer research education program that will prepare predoctoral and postdoctoral trainees as well as early-career researchers to apply systems and/or data science methods to community-engaged health disparities research. The goal is to accelerate the translation of research into practice to address real-world, complex health issues especially as they relate to health disparities. Use the link here for more information and to apply.
NEW – HerStory Women and Girls HIV Awareness and Women's History Month - Movie Screening: One Love The Bob Marley Story: Saturday, March 16, 2024
Us Helping Us People into Living Inc. will be collaborating with Georgetown University Women in Research to host the annual HerStory event (and other community organizations). The event will be held at the Alamo Drafthouse in Washington DC on Saturday March 16, 2024, from 11:00 am - 3:00 pm. We will feature a screening of One Love-The Bob Marley story. The HerStory event will bring awareness to Women and Girls through research, PrEP as well as networking. You can register for the event through our website. Please see the link here.
Seeking Input on the Next NIH Strategic Plan for HIV and HIV-Related Research; RFI due by March 28, 2024
"The NIH Office of AIDS Research (OAR) has issued a Request for Information (RFI) as one source of input to inform development of the FY 2026‒2030 NIH Strategic Plan for HIV and HIV-Related Research. Feedback from all interested constituents—including, but not limited to, researchers, health care professionals, advocates and health advocacy organizations, scientific or professional organizations, public health officials, government agencies, and community members—is a critical part of this process." More information available here.
Northwestern’s NIBIB-funded Center for Innovation in Point of Care Technologies for HIV and Emerging Infectious Diseases (C-THAN); Expression of Interest Due March 31st, 2024
C-THAN is specifically seeking proposals focused on increasing patient access to HIV viral load monitoring which may include the development of novel viral load diagnostics, technology that enables sample collection and/or plasma separation, field testing of assays in development, or implementation studies of current or near commercial tests. For more information and to apply, click here.
CDRF: 2024 CFAR HIV/AIDS Training Fellowship Awards, Seeking Indian National Applicant - Intent to Apply due by March 31st, 2024
CRDF Global is now accepting proposals from Centers for AIDS Research (CFARs) to support early-stage investigators from India working in the field of HIV/AIDS research for the 2024 CFAR HIV/AIDS Training Fellowship Awards. This two-year fellowship program aims to promote the training and inclusion of early-stage Indian scientists in HIV-related collaborative research within the CFAR program. Applications should come from CFARs and identify at least one Indian fellowship candidate. The initial intent to apply deadline is March 31, 2024; applications are due by July 31, 2024. For questions, please contact Annie King (aking@crdfglobal.org).
Workshop for Early Career Investigators in HIV, April 24, 2024, 11AM–4PM ET
The National Institutes of Health (NIH) Office of AIDS Research (OAR), along with the NIH institutes, centers, and offices (ICOs) with HIV research programs invite you to attend the Workshop for Early Career Investigators in HIV on Wednesday, April 24, 2024. OAR looks forward to building on the enthusiasm and feedback from the first two early career investigator (ECI) workshops in 2022 and 2023. OAR’s goal is to continue to provide knowledge, resources, and mentoring to the next generation of HIV investigators. Register here.
NEW – Inaugural Mid-Atlantic CFAR Consortium Nursing Initiative Meeting on May 3, 2024 at the Johns Hopkins School of Nursing. Registration due by April 21.
The MACC Nursing Initiative is hosting an inaugural conference to set a nursing-specific agenda to address our current HIV epidemic in the Mid-Atlantic region of our nation. This is a FREE conference (including registration, transportation within the region, parking, meals) and will include nursing experts as well as feature speakers from the NIH. Please spread the word to clinical and public health nurses, nursing faculty, students, and postdoctoral fellows with interests in HIV research. Register here!
Post-Doctoral (T32) Training Program in Ending the HIV Epidemic – Application Open at Emory University - Full applications are due May 3, 2024.
Emory Training Program in Translational Research to End the HIV Epidemic is now accepting applications to fill postdoctoral slots for January and July 2024. Interested and eligible candidates must complete an online interest form on or before April 12, 2024 to be connected to one of the Program Directors, Drs. Ann Chahroudi, Colleen Kelley, or Patrick Sullivan, to discuss their application. The program will offer a continuous rolling application and deadlines will vary depending on the intended start date. More information here.
NEW – The Dr. Dawn K. Smith HIV Prevention Clinical Fellowship, Applications due May 15, 2024
The Dr. Dawn K. Smith HIV Prevention Clinical Fellowship will provide comprehensive training to non-infectious disease clinicians in fields such as emergency medicine, family medicine, obstetrics and gynecology, pharmacy practice, primary care and others to increase PrEP awareness and utilization in under-resourced communities and in populations with higher HIV transmission rates. For more information, and application details, use the link here.
NEW – Gilead’s Research Scholars Program, Applications due July 8, 2024
Gilead’s Research Scholars Program supports independent basic and clinical research in the field of HIV throughout the US. Each of our successful applicants selected by an independent external committee of experts is provided with $180,000 USD paid as two annual installments to their institution. All information about the program can be found here.
| |
NIH FUNDING OPPORTUNITIES
| |
|
HIV Cure-Related Research in Diverse Populations
Funding Opportunity Number: NOT-AI-23-046
Posting Date: June 23, 2023
Opening Date: September 07, 2023
Close Date: May 08, 2026
HIV/AIDS Scholars Using Nonhuman Primate (NHP) Models Program (K01 Independent Clinical Trial Not Allowed)
Funding Opportunity Number: PAR-23-225
Posting Date: June 27, 2023
Opening Date: August 07, 2023
Close Date: Various – See announcement
Addressing the Impact of Syndemics on the Health of People with HIV and Diseases and Conditions within the Missions of NIDDK and NHLBI (R01 Clinical Trial Optional)
Funding Opportunity Number: RFA-DK-25-001
Posting Date: November 30, 2023
Opening Date: February 20, 2024
Close Date: Various – See announcement
Engineering and Preclinical Development of Biological Products that Eliminate HIV-infected Cells (UG3/UH3 Clinical Trial Not Allowed)
Funding Opportunity Number: RFA-AI-23-060
Posting Date: October 25, 2023
Opening Date: February 13, 2024
Close Date: March 14, 2024
Addressing the Impact of Structural Racism and Discrimination on Minority Health and Health Disparities (R01 - Clinical Trial Optional)
Funding Opportunity Number: PAR-23-112
Posting Date: January 31, 2023
Opening Date: February 24, 2023
Close Date: Various – See announcement
Engaging Survivors of Sexual Violence and Trafficking in HIV and Substance Use Disorder Services (R34 Clinical Trial Optional)
Funding Opportunity Number: RFA-DA-25-018
Posting Date: August 21, 2023
Opening Date: July 5, 2024
Close Date: August 2024
Addressing HIV in Highest Risk Sexual and Gender Minorities (R01 Clinical Trial Optional)
Funding Opportunity Number: RFA-DA-25-001
Posting Date: July 31, 2023
Opening Date: July 14, 2024
Close Date: August 14, 2024
Addressing HIV in highest risk sexual and gender minorities (R34 Clinical Trial Required)
Funding Opportunity Number: RFA-OD-23-018
Posting Date: July 31, 2023
Opening Date: July 14, 2024
Close Date: August 14, 2024
| |
|
NIAID New Innovators Awards (DP2 Clinical Trial Not Allowed)
Funding Opportunity Number: NOT-AI-23-046
Posting Date: June 3, 2023
Opening Date: September 13, 2023
Close Date: Various - See announcement
Opportunities for HIV Cure Strategies at the Time of ART Initiation (R01 Clinical Trial Not Allowed)
Funding Opportunity Number: PAR-23-297
Posting Date: September 19, 2023
Opening Date: December 07, 2023
Close Date: Various – See announcement
Resources Access for Preclinical Integrated Drug Development (RAPIDD) Program (X01 Clinical Trial Not Allowed)
Funding Opportunity Number: PAR-22-185
Posting Date: May 27, 2022
Opening Date: December 07, 2023
Close Date: Various – See announcement
NIAID New Innovators Awards (DP2 Clinical Trial Not Allowed)
Funding Opportunity Number: PAR-23-198
Posting Date: June 02, 2023
Opening Date: September 13, 2023
Close Date: Various – See announcement
Innovations to Optimize HIV Prevention and Care Continuum Outcomes (R01 Clinical Trial Optional)
Funding Opportunity Number: PAR-23-061
Posting Date: January 11, 2023
Opening Date: April 09, 2023
Close Date: January 10, 2026
Formative and Pilot Intervention Research to Optimize HIV Prevention and Care Continuum Outcomes (R34 Clinical Trial Optional)
Funding Opportunity Number: PAR-23-060
Posting Date: January 11, 2023
Opening Date: April 09, 2023
Close Date: January 10, 2026
Notice of Special Interest (NOSI): Implementation Science to Advance the United States HIV Prevention and Treatment Goals and the Global HIV Prevention and Treatment Targets
Funding Opportunity Number: NOT-MH-23-275
Posting Date: June 5, 2023
Opening Date: September 07, 2023
Close Date: September 08, 2026
Notice of Special Interest (NOSI): Research on HIV-associated Malignancies
Funding Opportunity Number: NOT-CA-23-070
Posting Date: June 5, 2023
Opening Date: September 07, 2023
Close Date: September 08, 2026
| |
Click here for additional funding opportunities available from the National Institutes of Health. | |
The DC CFAR is an NIH funded program (P30AI117970), which is supported by the following NIH Co-Funding and Participating Institutes and Centers: NIAID, NCI, NICHD, NIDCR, NHLBI, NIDA, NIMH, NIA, NIDDK, NINR, NIMHD, FIC, and OAR. The content isthe responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. | | |
| | | |
